VERMILLION, INC. License Agreements
3 Contracts & Agreements
- License Agreement between Aspira Womens Health Inc. and Dana-Farber Cancer Institute, Inc. effective March 20, 2023 (Filed With SEC on April 1, 2024)
- NON-EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on May 12, 2015)
- AMENDMENT ONE TO DISTRIBUTOR LICENSE AGREEMENT (Filed With SEC on March 15, 2004)
